Search research articles
Contact Us
Filters
Showing results (41-50 of 60) with videos related to
Page
of 6
Sort By:
Neurology(R) Neuroimmunology & Neuroinflammation
|
February 22, 2023
Immune Profiling Reveals the T-Cell Effect of Ocrelizumab in Early Relapsing-Remitting Multiple Sclerosis
Alexandra Garcia, Emilie Dugast, Sita Shah, et al.
Journal of the American Society of Nephrology : JASN
|
October 24, 2022
Effector Memory-Expressing CD45RA (TEMRA) CD8<sup>+</sup> T Cells from Kidney Transplant Recipients Exhibit Enhanced Purinergic P2X4 Receptor-Dependent Proinflammatory and Migratory Responses
Tra-My Doan Ngoc, Gaëlle Tilly, Richard Danger, et al.
Journal of Neuroinflammation
|
April 25, 2020
Outcome and risk of recurrence in a large cohort of idiopathic longitudinally extensive transverse myelitis without AQP4/MOG antibodies
Elisabeth Maillart, Françoise Durand-Dubief, Céline Louapre, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
September 23, 2020
Relapses in Patients Treated with High-Dose Biotin for Progressive Multiple Sclerosis
Sophie Mathais, Xavier Moisset, Bruno Pereira, et al.
JAMA Network Open
|
June 23, 2023
Association Between Anti-CD20 Therapies and COVID-19 Severity Among Patients With Relapsing-Remitting and Progressive Multiple Sclerosis
Edouard Januel, David Hajage, Pierre Labauge, et al.
Frontiers in Immunology
|
January 23, 2025
Blood immunophenotyping of multiple sclerosis patients at diagnosis identifies a classical monocyte subset associated to disease evolution
Stéphane Rodriguez, Laura Couloume, Juliette Ferrant, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 22, 2024
COVID-19 outcomes in patients with multiple sclerosis: Understanding changes from 2020 to 2022
Lina Jeantin, Edouard Januel, Pierre Labauge, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
June 1, 2019
Frequency and characteristics of short versus longitudinally extensive myelitis in adults with MOG antibodies: A retrospective multicentric study
Jonathan Ciron, Alvaro Cobo-Calvo, Bertrand Audoin, et al.
JAMA
|
March 10, 2025
High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical Trial
Eric Thouvenot, David Laplaud, Christine Lebrun-Frenay, et al.
Neurology
|
April 27, 2018
Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: The MOGADOR study
Alvaro Cobo-Calvo, Anne Ruiz, Elisabeth Maillart, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 60) with videos related to
Sort By:
Page
of 6
Neurology(R) Neuroimmunology & Neuroinflammation
|
February 22, 2023
Immune Profiling Reveals the T-Cell Effect of Ocrelizumab in Early Relapsing-Remitting Multiple Sclerosis
Alexandra Garcia, Emilie Dugast, Sita Shah, et al.
Journal of the American Society of Nephrology : JASN
|
October 24, 2022
Effector Memory-Expressing CD45RA (TEMRA) CD8<sup>+</sup> T Cells from Kidney Transplant Recipients Exhibit Enhanced Purinergic P2X4 Receptor-Dependent Proinflammatory and Migratory Responses
Tra-My Doan Ngoc, Gaëlle Tilly, Richard Danger, et al.
Journal of Neuroinflammation
|
April 25, 2020
Outcome and risk of recurrence in a large cohort of idiopathic longitudinally extensive transverse myelitis without AQP4/MOG antibodies
Elisabeth Maillart, Françoise Durand-Dubief, Céline Louapre, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
September 23, 2020
Relapses in Patients Treated with High-Dose Biotin for Progressive Multiple Sclerosis
Sophie Mathais, Xavier Moisset, Bruno Pereira, et al.
JAMA Network Open
|
June 23, 2023
Association Between Anti-CD20 Therapies and COVID-19 Severity Among Patients With Relapsing-Remitting and Progressive Multiple Sclerosis
Edouard Januel, David Hajage, Pierre Labauge, et al.
Frontiers in Immunology
|
January 23, 2025
Blood immunophenotyping of multiple sclerosis patients at diagnosis identifies a classical monocyte subset associated to disease evolution
Stéphane Rodriguez, Laura Couloume, Juliette Ferrant, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 22, 2024
COVID-19 outcomes in patients with multiple sclerosis: Understanding changes from 2020 to 2022
Lina Jeantin, Edouard Januel, Pierre Labauge, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
June 1, 2019
Frequency and characteristics of short versus longitudinally extensive myelitis in adults with MOG antibodies: A retrospective multicentric study
Jonathan Ciron, Alvaro Cobo-Calvo, Bertrand Audoin, et al.
JAMA
|
March 10, 2025
High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical Trial
Eric Thouvenot, David Laplaud, Christine Lebrun-Frenay, et al.
Neurology
|
April 27, 2018
Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: The MOGADOR study
Alvaro Cobo-Calvo, Anne Ruiz, Elisabeth Maillart, et al.
Page
of 6